Exabis Library
Welcome to the e-CCO Library!
P319: Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn’s disease on adalimumab maintenance therapy
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P320 Thrombocytosis in acute inflammatory bowel disease: a useful biomarker?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P320: 6-Thioguanine nucleotide levels are associated with trough levels of infliximab and adalimumab in Inflammatory Bowel Disease patients on combination therapy: A retrospective multicentre study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P320: Accuracy of faecal calprotectin level to select patients with inflammatory bowel disease for a chromoendoscopy surveillance programme
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P320: Clinical and economic effect of short infliximab infusion protocol in patients with inflammatory bowel diseases: a multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P320: Combined mesenchymal stromal cells and anti-cytokine therapy of perianal Crohn's disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P320: Confocal Laser Endomicroscopy to predict the efficacy of vedolizumab as first-line biotherapy in ulcerative colitis
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P320: High Cytomegalovirus DNA load in mucosal biopsies predicts steroid failure as well as colectomy in acute severe ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P320: Utility of a semi-quantitative rapid test in diagnosis of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P321 Prognosis of intestinal Behcet’s disease according to the Korean consensus-based diagnostic algorithm
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P321: Activity graph patterns recorded using a mobile monitoring system are associated with clinical outcomes of patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P321: Cessation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn’s Disease: Individual Patient Data Meta-Analysis of 323 patients from 12 studies
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P321: Increased modified DUBLIN scores are associated with serious ulcerative colitis and treatment failure
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P321: Mucosal Healing and Clinical remission after Treatment with Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA study): final results from a prospective, open-label, single-arm study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P321: Mucosal healing in a cohort of inflammatory bowel diseases paediatric patients in clinical remission
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P321: On effectiveness, safety, and TDM of thioguanine in a cohort of 274 patients with IBD, intolerant for conventional thiopurines
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P321: Ulcerative colitis: Role of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting disease severity
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P322 Impact of the presence of Epstein–Barr virus in intestinal mucosa of inflammatory bowel disease patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P322: A change in ΔMCV predicts mucosal healing in patients with Crohn's disease under combination therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P322: Complications to parenteral therapy in patients with intestinal failure because of inflammatory bowel disease: A retrospective cohort study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM